APA (7th ed.) Citation

I, R., L, G., A, L., PL, C., TF, A., LJA, E., . . . A, M. (2025). HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer. Oncoimmunology, 14(1), 2598920. https://doi.org/10.1080/2162402X.2025.2598920

Chicago Style (17th ed.) Citation

I, Ruiz-Lorente, et al. "HLA Class-I Genotyping to Personalize Bacille Calmette-Guerin Immunotherapy in Bladder Cancer." Oncoimmunology 14, no. 1 (2025): 2598920. https://doi.org/10.1080/2162402X.2025.2598920.

MLA (9th ed.) Citation

I, Ruiz-Lorente, et al. "HLA Class-I Genotyping to Personalize Bacille Calmette-Guerin Immunotherapy in Bladder Cancer." Oncoimmunology, vol. 14, no. 1, 2025, p. 2598920, https://doi.org/10.1080/2162402X.2025.2598920.